Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for peptide receptor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- Quadriceps expression profiles in MNST nulls and in WT treated with a soluble ActIIB receptor
Most Relevant Literature
- Adverse maternal environment alters Oprl1 variant expression in mouse hippocampus.
- Computational Design of Plant-Based Antistress Agents Targeting Nociceptin Receptor.
- Nociceptin Receptor Antagonism Modulates Electrophysiological Markers of Reward Learning.
- Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics.
- A genome-wide association study of European advanced cancer patients treated with opioids identifies…
Most Relevant Clinical Trials
- Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors…
- Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors
- Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
- A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects
- Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
